Right after coming off of the hurt checklist to commence yesterday, Nationals ace Max Scherzer woke up with renewed stiffness in his back again, Mark Zuckerman of MASNsports.com reports. It is not obvious at this stage no matter if he’ll skip his following scheduled get started and/or demand a return excursion to the 10-working day IL.
An MRI taken this early morning disclosed a delicate rhomboid strain. That is a diverse challenge in the very same place of the higher back/shoulder. Scherzer experienced formerly been working with an inflamed bursa sac in the vicinity of his shoulder blade. To treat the new dilemma, Scherzer has undergone a stem-cell injection. His response to that will be assessed in a number of days.
While the Nats need each individual one Scherzer outing they can get, the team is also walking a little bit of a tightrope. Enabling the fiery veteran to push himself also tricky could effortlessly backfire. And Scherzer was not fairly at his greatest in his return start off, however he was even now powerful and did emphasize that he felt at complete overall health likely into and throughout the outing.
The uncertainty bordering Scherzer arrives at an fascinating time for the Nationals. There was now a case to be built that this workforce could use a beginning pitcher. There’s all the more cause to do so now, if only to acquire some time to give Scherzer sufficient rest.
A single route would be to get a fill-in rotation piece that can check down to a reduction position. Derek Holland might’ve designed feeling in that capacity, specifically since the Nats could use a southpaw and he has been so awful in opposition to opposing lefties. But the staff didn’t leap on the option, with Holland landing now with the Cubs. Equivalent hurlers could however make perception. The rough factor for the D.C. group will be to balance the vital to buttress the rotation with a even now-obtrusive need to have for numerous, excellent reduction arms.